NCT00016549View on ClinicalTrials.gov

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 13, 2001

Primary Completion Date

January 29, 2007

Study Completion Date

January 29, 2007

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Bevacizumab

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00016549 - Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter